Solazyme Lands $52,000,000 Series D Financing

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    225 Gateway Blvd. South San Francisco, CA 94080
  • Company Description
    Solazyme is a biotechnology company devoted to harnessing the energy-harvesting machinery of photosynthetic microbes to produce valuable products. Exploiting microbial photosynthesis, a biochemical system benefiting from 2.5 billion years of evolutionary optimization yet brought to genomic light very recently, the Company utilizes proprietary genetic engineering methods to develop commercially relevant, sunlight-driven biochemical pathways.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series D
  • Proceeds Purposes
    Proceeds purpose were not disclosed.
  • M&A Terms
  • Venture Investor
    Morgan Stanley Venture Partners
  • Venture Investor
    Braemar Energy Ventures
  • Venture Investor
    Lightspeed Venture Partners
  • Venture Investor
    The Roda Group
  • Venture Investor
    Harris & Harris Group
  • Venture Investor
    VantagePoint Venture Partners
  • Venture Investor
    Zygote Ventures
  • Venture Investor
    Chevron Technology Ventures

Trending on Xconomy